Clarity Pharmaceuticals Ltd News

Clarity Pharmaceuticals Ltd: Final Director's Interest Notice - Rob Thomas

Aug 26 10:20

Clarity Pharmaceuticals Ltd: FDA Fast Track Designation 64CU-SAR-bisPSMA

Aug 22 08:03

Clarity Pharmaceuticals Ltd: Change of Director's Interest Notice - Biggin

Aug 12 13:55

Clarity Pharmaceuticals Ltd: Change of Director's Interest Notice - Biggin

Aug 5 11:57

Clarity Pharmaceuticals Ltd: Change of Director's Interest Notice - Taylor

Aug 2 09:29

Clarity Pharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 31 08:22

Clarity Pharmaceuticals Ltd: Supply agreement for Ac-225 with TerraPower Isotopes

Jul 16 07:13

Clarity Pharmaceuticals Ltd: Clarity Receives $10 million R&D Tax Incentive

Jun 24 12:03

Clarity Pharmaceuticals Ltd: Clarity Confirms No Supply Disruptions for Clinical Trials

Jun 7 08:05

Clarity Pharmaceuticals Ltd: Clarity strengthens Cu-64 network with new supply agreement

May 30 06:23

Clarity Pharmaceuticals Ltd: Change of Director's Interest Notice - Rob Thomas

May 22 14:11

Clarity Pharmaceuticals Ltd: Clarity to Present at 3 World Leading Conferences

May 3 07:51

Clarity Pharmaceuticals Ltd: Change of Director's Interest Notice - Thomas

Apr 30 14:04

Clarity Pharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 30 13:37

Clarity Pharmaceuticals Ltd: Complete response with Cu-67 SAR-bisPSMA

Apr 30 07:37

Clarity Pharmaceuticals Ltd: Clarity enters into Clinical Supply Agreement

Apr 4 06:47

Clarity Pharmaceuticals Ltd: Trading Halt

Mar 25 06:51

Clarity Pharmaceuticals Ltd: First participant treated in the last dose escalation cohort

Mar 22 06:29

Clarity Pharmaceuticals Ltd: Change of Director's Interest Notice

Mar 21 06:49

Clarity Pharmaceuticals Ltd: Theranostic prostate cancer trial advances to multi-dose

Mar 15 07:45